Lipoflow™ Oral Liposomal Myers Cocktail
Contains 1 serving of Oral Myers Cocktail per 2 ounce bottle.
Contains 5.5 grams of Essential Phospholipids per ounce.
A Natural Essential Phospholipid (EPL)
Anti-Aging Nutritional Supplement for Oral Application, Plus Benefits Similar to Statin Drugs (but without the side effects)
from the addition of Essential Phospholipids (that make up the liposomes).
The Myers Cocktail is named for the late
John Myers, M.D., a Maryland physician, who used intravenous injections to improve nutrition. Directions: As
a Nutritional Supplement take 2 ounces daily, or as prescribed by a physician. Gently stir product into about 2 ounces of
water or juice and take orally.
Physicians: Dose and frequency of oral administration is the
same as for intravenous administration.
Supplement Facts: Serving Size: 2 Ounces
Each 2 ounce serving contains: Distilled Water, Essential Phospholipds, Ascorbic Acid (1200 mg), Magnesium Chloride
(1000 mg), Pyridoxine (102 mg), Dex-Panthenol (252 mg), Thiamine (100mg), Niacinamide (100 mg), Vitamin B12 (10 mg), Riboflavine
(2 mg). (*) Daily Value not established.
Manufactured in the USA. Keep out of reach of children. Store in
a cool dry place.
Health and Anti-Aging Benefits of Natural Essential Phospholipid (EPL) Nutritional
Supplements Similar to Statin Drugs but without Side Effects.
Liposomes consist of Essential Phospholipids
(EPL) which are natural substances that form the outer membrane of every living cell in humans and animals. The following
are a description of the additional vascular benefits of LipoFlow™ EPL products.
Essential Phospholipds (EPL)
have shown the following cardiovascular benefits in over 100 clinical trials in Europe and in the US for doses as low as 1
gm of EPL per day. All LipoFlow™ products approach intravenous level assimilation through micro encapsulation in an
EPL oral delivery system. • Clinical Studies (controlled against diet, double blinded placebo controlled or open)
show substantial improvements in lowering Mean Total Serum Cholesterol (12% to 25%).
decrease in LDL (so called "bad cholesterol") in double blind clinical studies with LDL with reduction ranging to
• Significant increase in HDL (so called "good cholesterol") was observed by 5 different
clinicl researchers varying from 50% to 100% increase after 1 to 3 months treatment.
reduction in serum triglycerides.
• Very substantial lowering of cardiovasvular risk ratio 5.6 reduction
to 3.7 in a double blind trial (Kirsten, R.) 4.3 reduction to 2.8 in a 4-week open study. (Goto, Y., Nakamura H.) See EPL Clinical Studies; see references
Increased peripheral and brain circulation.
• Decreased reactive platelet aggregation in patients
with agina pectories (60% lower).
• Significant decrease in anginal (chest pain stage III and IV)
attacks or in some patients a total elimination of aginal attacks (chest pain).
• Exercise tolerance
with angina prone patients increased as much as 200% before anginal pain is observed or nitro glycerine is required.
Please Note: Nothing contained on this website is intended to constitute as professional advice for medical diagnosis or
treatment. You should not use the information on this site for diagnosis, or treatment of any health problem. The products
and statements about specific products on this site have not been evaluated by the United States Food and Drug Administration.
Our products are not intended to diagnose, treat, cure, or prevent any disease.